Terms: = Breast cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Treatment
246 results:
1. Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.
Boulifa A; Raftery MJ; Franzén AS; Radecke C; Stintzing S; Blohmer JU; Pecher G
BMC Cancer; 2024 Mar; 24(1):339. PubMed ID: 38486205
[TBL] [Abstract] [Full Text] [Related]
2. Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer.
Somboonpatarakun C; Phanthaphol N; Suwanchiwasiri K; Ramwarungkura B; Yuti P; Poungvarin N; Thuwajit P; Junking M; Yenchitsomanus PT
Int Immunopharmacol; 2024 Mar; 129():111631. PubMed ID: 38359664
[TBL] [Abstract] [Full Text] [Related]
3. Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development.
Hosseinkhani N; Hemmat N; Baghbani E; Baghbanzadeh A; Kazemi T; Mokhtarzadeh A; Jafarlou M; Amin Doustvandi M; Baradaran B
Gene; 2024 Feb; 896():148043. PubMed ID: 38042220
[TBL] [Abstract] [Full Text] [Related]
4. cancer-related fatigue: Towards a more targeted approach based on classification by biomarkers and psychological factors.
Schmidt ME; Maurer T; Behrens S; Seibold P; Obi N; Chang-Claude J; Steindorf K
Int J Cancer; 2024 Mar; 154(6):1011-1018. PubMed ID: 37950650
[TBL] [Abstract] [Full Text] [Related]
5. treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns.
Gougis P; Grandal B; Jochum F; Bihan K; Coussy F; Barraud S; Asselain B; Dumas E; Sebbag C; Hotton J; Spaggiari E; Pierga JY; Savarino R; Laas E; Spano JP; Reyal F; Hamy AS
JAMA Netw Open; 2023 Oct; 6(10):e2339934. PubMed ID: 37883083
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer.
Jacover A; Zarbiv Y; Tal KH; Klein S; Breuer S; Durst R; Avni B; Grisariu S; Stepensky P; Lotem M; Maimon O; Yablonski-Peretz T
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1894. PubMed ID: 37750497
[TBL] [Abstract] [Full Text] [Related]
7. Amygdalin-folic acid-nanoparticles inhibit the proliferation of breast cancer and enhance the effect of radiotherapy through the modulation of tumor-promoting factors/ immunosuppressive modulators in vitro.
Askar MA; El-Sayyad GS; Guida MS; Khalifa E; Shabana ES; Abdelrahman IY
BMC Complement Med Ther; 2023 May; 23(1):162. PubMed ID: 37210478
[TBL] [Abstract] [Full Text] [Related]
8. Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic cancer.
Tsimberidou AM; Guenther K; Andersson BS; Mendrzyk R; Alpert A; Wagner C; Nowak A; Aslan K; Satelli A; Richter F; Kuttruff-Coqui S; Schoor O; Fritsche J; Coughlin Z; Mohamed AS; Sieger K; Norris B; Ort R; Beck J; Vo HH; Hoffgaard F; Ruh M; Backert L; Wistuba II; Fuhrmann D; Ibrahim NK; Morris VK; Kee BK; Halperin DM; Nogueras-Gonzalez GM; Kebriaei P; Shpall EJ; Vining D; Hwu P; Singh H; Reinhardt C; Britten CM; Hilf N; Weinschenk T; Maurer D; Walter S
Cancer Immunol Res; 2023 Jul; 11(7):925-945. PubMed ID: 37172100
[TBL] [Abstract] [Full Text] [Related]
9. Engineering an active immunotherapy for personalized cancer treatment and prevention of recurrence.
Wu K; Lyu F; Wu SY; Sharma S; Deshpande RP; Tyagi A; Zhao D; Xing F; Singh R; Watabe K
Sci Adv; 2023 Apr; 9(17):eade0625. PubMed ID: 37126558
[TBL] [Abstract] [Full Text] [Related]
10. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells.
Donnenberg VS; Luketich JD; Sultan I; Lister J; Bartlett DL; Ghosh S; Donnenberg AD
Front Immunol; 2023; 14():1157697. PubMed ID: 37063842
[TBL] [Abstract] [Full Text] [Related]
11. Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with cancer.
McKenzie DR; Graham R; Lechmere T; Domingo-Vila C; Alaguthurai T; Arman C; Pollock E; Gousis C; Kakkassery H; Carpenter E; Kurshan A; Vidler J; Kulasekararaj A; Patten P; North BV; Tree T; Doores KJ; Hayday AC; Irshad S
Cancer Res Commun; 2022 Nov; 2(11):1449-1461. PubMed ID: 36824220
[TBL] [Abstract] [Full Text] [Related]
12. Fish Oil and Selenium with Doxorubicin Modulates Expression of Fatty Acid Receptors and Selenoproteins, and Targets Multiple Anti-cancer Signaling in Triple-negative breast cancer Tumors.
Guo CH; Shih MY; Chung CH; Lin YC; Fan CT; Peng CL; Chen PC; Hsia S
Int J Med Sci; 2022; 19(14):2044-2057. PubMed ID: 36483592
[TBL] [Abstract] [Full Text] [Related]
13. Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.
Rivas EI; Linares J; Zwick M; Gómez-Llonin A; Guiu M; Labernadie A; Badia-Ramentol J; Lladó A; Bardia L; Pérez-Núñez I; Martínez-Ciarpaglini C; Tarazona N; Sallent-Aragay A; Garrido M; Celià-Terrassa T; Burgués O; Gomis RR; Albanell J; Calon A
Nat Commun; 2022 Sep; 13(1):5310. PubMed ID: 36085201
[TBL] [Abstract] [Full Text] [Related]
14. Immunomodulatory roles of propofol and sevoflurane in murine models of breast cancer.
Yan R; Song T; Wang W; Tian J; Ma X
Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):153-159. PubMed ID: 36073191
[TBL] [Abstract] [Full Text] [Related]
15. Bioactivity of Exosomes Derived from Trained Natural Killer Cells versus Non-Trained One: More Functional and Antitumor Activity.
Mohammadi F; Hashemi ZS; Forooshani RS; Alizadeh S
Biomed Res Int; 2022; 2022():5396628. PubMed ID: 36060136
[TBL] [Abstract] [Full Text] [Related]
16. Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
Huang DT; McCreary EK; Bariola JR; Minnier TE; Wadas RJ; Shovel JA; Albin D; Marroquin OC; Kip KE; Collins K; Schmidhofer M; Wisniewski MK; Nace DA; Sullivan C; Axe M; Meyers R; Weissman A; Garrard W; Peck-Palmer OM; Wells A; Bart RD; Yang A; Berry LR; Berry S; Crawford AM; McGlothlin A; Khadem T; Linstrum K; Montgomery SK; Ricketts D; Kennedy JN; Pidro CJ; Nakayama A; Zapf RL; Kip PL; Haidar G; Snyder GM; McVerry BJ; Yealy DM; Angus DC; Seymour CW
JAMA Netw Open; 2022 Jul; 5(7):e2220957. PubMed ID: 35834252
[TBL] [Abstract] [Full Text] [Related]
17. Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC.
Harrasser M; Gohil SH; Lau H; Della Peruta M; Muczynski V; Patel D; Miranda E; Grigoriadis K; Grigoriadis A; Granger D; Evans R; Nathwani AC
Breast Cancer Res; 2022 Jun; 24(1):39. PubMed ID: 35659040
[TBL] [Abstract] [Full Text] [Related]
18. The TLR7/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer.
Zhou J; Xu Y; Wang G; Mei T; Yang H; Liu Y
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35552764
[TBL] [Abstract] [Full Text] [Related]
19. Decrease of Tumor-infiltrating Regulatory T Cells Using Pentoxifylline: An Ex Vivo Analysis in Triple-negative breast cancer Mouse Model.
Kazemi MH; Shokrollahi Barough M; Ghanavatinejad A; Momeni-Varposhti Z; Khorrami S; Sadeghi B; Falak R
Iran J Allergy Asthma Immunol; 2022 Apr; 21(2):167-177. PubMed ID: 35490270
[TBL] [Abstract] [Full Text] [Related]
20. Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of breast cancer Cells to Radiotherapy.
Guo LM; Ding GF; Xu WC; Ge H; Jiang Y; Lu YF
Oxid Med Cell Longev; 2022; 2022():5938688. PubMed ID: 35295718
[TBL] [Abstract] [Full Text] [Related]
[Next]
